Factor Therapeutics Ltd (FTT)
20mins delayed
Movement
1 Year Return
Factor Therapeutics Ltd Chart
| Share price | |
| Last | |
| Change | |
| Volume | |
| Turnover | |
| Market Cap | $5.21 million |
| Today's Movement | |
| Prev. Close | |
| Open | |
| Day Range | - |
| VWAP | |
| Historical Stats | |
| 52w Range | - |
| 4w Avg Volume | |
| 4w Avg Turnover | |
| (delayed) | |
FTT Statistics
19 January
2,254 / 2,256
ASX Size Rank
1yr Return
vs Sector (1yr)
+55.03%
vs ASX 200 (1yr)
+71.43%
$5.21 million
Market Cap
Share Issue
1.04 billion
All Ords (%)
N/A
Short Sold
0%
Current Fundamentals
19 January
25
PE Ratio
EPS ($)
0
Earnings Yield
4.00%
NTA ($)
-
0.00%
Dividend Yield
DPS ($)
-
Gross Div. Yield
-
Gross DPS ($)
-
Company Overview
Factor Therapeutics (FTT, formerly Tissue Therapies Limited) is a clinical-stage life sciences company. It develops treatments for acute and chronic wound healing applications, including chronic skin ulcers and burns. FTT is commercialising VF-001, a technology for cell based therapies. FTT is also developing treatments for psoriasis, scar prevention and various cancers including those of the breast, colon and prostate.
Former Names
Tissue Therapies Limited (TIS), 04/05/2016
Upcoming Calendar
| 17 Feb 2021 | Report (Prelim) |
| 17 Feb 2021 | Report (Annual) |
| 28 Jul 2021 | Report (Interim) |
Dividend History
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| No dividends paid in the last 5 years | ||||
See Upcoming Dividends for all ASX companies.
Announcements
| Date | Heading | Pages | File Size | Time |
|---|---|---|---|---|
Announcements provided by
Broker Consensus
The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.
FTT is not covered by a major broker,
or data from most recent compilation was omitted due
to not meeting QA guidelines.
Directors & Management
| Name | Title | Since | Bio |
|---|---|---|---|
| Dr David Lionel Brookes | Non-Executive Director, Non-Executive Chairman | Apr 2019 |
|
| Dr Christian Peter Behrenbruch | Non-Executive Director | Oct 2015 |
|
| Mr John Michailidis | Non-Executive Director | Feb 2017 |
|
Director Transactions
FTT directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
| Date | Director | Type | Amount | Price | Value | Notes |
|---|---|---|---|---|---|---|
| 19/04/18 | Cherrell Hirst | Issued | 474,830 | $0.040 | $18,993 | Rights issue. |
| 19/04/18 | Christian Behrenbruch | Issued | 408,164 | $0.040 | $16,326 | Rights issue. |
| 19/04/18 | John Michailidis | Issued | 527,432 | $0.040 | $21,097 | Rights issue. |
| 17/11/17 | John Michailidis | Issued | 1,000,000 | $0.050 | $50,000 | Issue of options. |
| 23/11/16 | Robert Ryan | Issued | 1,000,000 | $0.081 | $81,000 | |
| 26/07/16 | Christian Behrenbruch | Issued | 4,000,000 | $0.043 | $172,000 | |
| 26/07/16 | Cherrell Hirst | Buy | +2,857,142 | $0.035 | $99,999 | |
| 26/07/16 | Christian Behrenbruch | Buy | +2,857,142 | $0.035 | $99,999 | |
| 26/04/16 | Cherrell Hirst | Issued | 133,334 | $0.035 | $4,666 |
Shareholder Distribution
| Holding Size | 1 - 1,000 | 1,001 - 5,000 | 5,001 - 10,000 | 10,001 - 100,000 | 100,001 and over | Total Shareholders |
|---|---|---|---|---|---|---|
| No. of Shareholders | 200 | 84 | 178 | 1,021 | 668 | 2,151 |
Top 20 Shareholders
| Name | Shares | Capital |
|---|---|---|
| Mr Nicholas Dermott Mcdonald | 42,845,239 | 4.11% |
| Calama Holdings Pty Ltd | 40,000,000 | 3.84% |
| Yelwac Pty Ltd | 29,094,216 | 2.79% |
| Citicorp Nominees Pty Limited | 28,928,379 | 2.77% |
| GP Securities Pty Ltd | 28,607,989 | 2.74% |
| Corporate Property Services Pty Ltd | 24,472,986 | 2.35% |
| 1215 Capital Pty Ltd | 21,807,708 | 2.09% |
| HSBC Custody Nominees (Australia) Limited | 20,278,880 | 1.94% |
| Wisevest Pty Ltd | 20,000,000 | 1.92% |
| Symington Pty Ltd | 19,700,000 | 1.89% |
| L X X X I X Pty Ltd | 17,964,167 | 1.72% |
| Sailors Of Samui Pty Ltd | 15,000,000 | 1.44% |
| Mr Michael Andrew Whiting & Mrs Tracey Anne Whiting | 12,876,085 | 1.23% |
| Nurragi Investments Pty Ltd | 12,850,000 | 1.23% |
| Octifil Pty Ltd | 12,134,706 | 1.16% |
| Wymond Investments Pty Ltd | 12,000,000 | 1.15% |
| Harold Cripps Holdings Pty Ltd | 11,623,027 | 1.11% |
| Mr Peter Anthony Whiting & Mrs Jane Mary Whiting | 11,305,349 | 1.08% |
| Mrs Cheryl Ann Nairn | 11,000,000 | 1.05% |
| Mr Nicholas Dermott Mc Donald | 10,000,000 | 0.96% |
| Mr Andrew David Mintz & Mrs Annette Joy Mintz | 10,000,000 | 0.96% |
| Mr Francis Xavier Parnis & Mrs Sally Jane Parnis | 10,000,000 | 0.96% |
| J & D Lawrence Pty Ltd | 10,000,000 | 0.96% |
| Jetosea Pty Ltd | 10,000,000 | 0.96% |
| Annlew Investments Pty Ltd | 10,000,000 | 0.96% |
| Dinwoodie Investments Pty Ltd | 10,000,000 | 0.96% |
| Dolphin Capital Partners Pty Ltd | 10,000,000 | 0.96% |
| Dr Alok Jhamb | 10,000,000 | 0.96% |
| Puntero Pty Ltd | 10,000,000 | 0.96% |
| All other shareholders | 52.79 % | |
The Top 20 Shareholders of FTT hold 47.21% of shares on issue.
FTT Share Price History
| Date | Close | Change | % Change | Open | High | Low | Volume | Turnover |
|---|---|---|---|---|---|---|---|---|
FTT Historical Data
Download up to 20 years of share price history.
| Year | Closing Price (30 June) | Last Trade |
|---|---|---|
| 2020 | $0.003 | 30 June |
| 2019 | $0.004 | 28 June |
| 2018 | $0.047 | 29 June |
| 2017 | $0.062 | 28 June |
| 2016 | $0.034 | 28 June |
Offical data as published by ASX. See more Data Downloads.
Company Details
Principal Activity: Identification and diligence of potential new business opportunities for the Company.
Incorporated: Tissue Therapies Limited was incorporated on 6 September 2002 in Queensland
-
-
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.